Uncovering Vaccine Adjuvants from Toll-like Receptor 4 Agonist

被引：0
|
作者：
Romaine, Marian [1 ]
机构：
[1] CUNY Hunter Coll, New York, NY USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
基金：
美国国家卫生研究院;
关键词：
Toll-like Receptor 4; Anti-inflammatory; phytochemical; vaccine adjuvants; Lipopolysaccharide;
D O I：
10.1016/j.jbc.2024.106024
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2030
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [1] Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine
    Sajadian, Azadeh
    Tabarraei, Alijan
    Soleimanjahi, Hoorieh
    Fotouhi, Fatemeh
    Gorji, Ali
    Ghaemi, Amir
    ARCHIVES OF VIROLOGY, 2014, 159 (08) : 1951 - 1960
  • [2] Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine
    Azadeh Sajadian
    Alijan Tabarraei
    Hoorieh Soleimanjahi
    Fatemeh Fotouhi
    Ali Gorji
    Amir Ghaemi
    Archives of Virology, 2014, 159 : 1951 - 1960
  • [3] Toll-like receptor agonists as cancer vaccine adjuvants
    Jeon, Donghwan
    Hill, Ethan
    Mcneel, Douglas G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [4] Polymer conjugates of toll-like receptor ligands as vaccine adjuvants
    Lynn, G.
    Laga, R.
    Fisher, K.
    Seder, R.
    Seymour, L.
    HUMAN GENE THERAPY, 2011, 22 (10) : A70 - A70
  • [5] Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents
    Baldridge, JR
    McGowan, P
    Evans, JT
    Cluff, C
    Mossman, S
    Johnson, D
    Persing, D
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) : 1129 - 1138
  • [6] Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
    Yang, Jing-Xing
    Tseng, Jen-Chih
    Yu, Guann-Yi
    Luo, Yunping
    Huang, Chi-Ying F.
    Hong, Yi-Ren
    Chuang, Tsung-Hsien
    PHARMACEUTICS, 2022, 14 (02)
  • [7] Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
    Bhagchandani, Sachin
    Johnson, Jeremiah A.
    Irvine, Darrell J.
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 175
  • [8] The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
    Vasilakos, John P.
    Tomai, Mark A.
    EXPERT REVIEW OF VACCINES, 2013, 12 (07) : 809 - 819
  • [9] E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant
    Ishizaka, Sally T.
    Hawkins, Lynn D.
    EXPERT REVIEW OF VACCINES, 2007, 6 (05) : 773 - 784
  • [10] Toll-Like Receptor Agonists Are They Good Adjuvants?
    Gnjatic, Sacha
    Sawhney, Nikhil B.
    Bhardwaj, Nina
    CANCER JOURNAL, 2010, 16 (04): : 382 - 391
12345